Research ArticleEndocrine and Diabetes
TAK-875, an Orally Available G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonist, Enhances Glucose-Dependent Insulin Secretion and Improves Both Postprandial and Fasting Hyperglycemia in Type 2 Diabetic Rats
Yoshiyuki Tsujihata, Ryo Ito, Masami Suzuki, Ayako Harada, Nobuyuki Negoro, Tsuneo Yasuma, Yu Momose and Koji Takeuchi
Journal of Pharmacology and Experimental Therapeutics October 2011, 339 (1) 228-237; DOI: https://doi.org/10.1124/jpet.111.183772
Yoshiyuki Tsujihata
Ryo Ito
Masami Suzuki
Ayako Harada
Nobuyuki Negoro
Tsuneo Yasuma
Yu Momose

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleEndocrine and Diabetes
GPR40 Agonist as a Potential Antidiabetic Drug
Yoshiyuki Tsujihata, Ryo Ito, Masami Suzuki, Ayako Harada, Nobuyuki Negoro, Tsuneo Yasuma, Yu Momose and Koji Takeuchi
Journal of Pharmacology and Experimental Therapeutics October 1, 2011, 339 (1) 228-237; DOI: https://doi.org/10.1124/jpet.111.183772
Research ArticleEndocrine and Diabetes
GPR40 Agonist as a Potential Antidiabetic Drug
Yoshiyuki Tsujihata, Ryo Ito, Masami Suzuki, Ayako Harada, Nobuyuki Negoro, Tsuneo Yasuma, Yu Momose and Koji Takeuchi
Journal of Pharmacology and Experimental Therapeutics October 1, 2011, 339 (1) 228-237; DOI: https://doi.org/10.1124/jpet.111.183772
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement